Volex lifts its FY2026 revenue guidance above market expectations, fueled by booming AI and data centre demand, while maintaining strong operating margins.
This article covers information on Volex PLC.
LON:VLXVolex has delivered another strong quarter. For the nine months to 31 December 2025, Group revenue hit $902.7 million, up 14.8% on an organic constant currency basis. That momentum is flowing into outlook: the Board now expects full-year revenue to be ahead of current market consensus, with underlying operating margins sustained and expectations for underlying operating profit increased.
In plain English: growth is broad-based, the profit engine is running near the top end of its target range, and management is confident enough to guide above the street for revenue.
| Metric | Detail |
|---|---|
| 9M FY2026 revenue | $902.7 million |
| Organic constant currency growth | 14.8% (nine months) |
| Underlying operating margin (YTD) | Around the upper end of 9-10% target range |
| Covenant leverage | Around 1.0x |
| Market consensus revenue (FY to 31 Mar 2026) | $1,152.3 million (range: $1,145.1m-$1,167.4m) |
| Market consensus underlying operating profit | $112.7 million (range: $111.7m-$114.9m) |
| Company outlook | Revenue ahead of consensus; margins sustained; higher expectations for underlying operating profit |
The standout is Complex Industrial Technology, where Volex is benefitting from “continued, elevated” demand from Data Centre customers. That is AI by another name: hyperscaler and enterprise build-outs for AI and digital infrastructure are still accelerating, and Volex is selling into that wave.
The company also notes robust growth from other industrial customers, suggesting the strength is not a single-customer flash in the pan. That diversification matters when some other end markets are more mixed.
Net-net: Volex’s exposure to structurally attractive areas like Data Centres is more than offsetting cyclical or customer-specific headwinds in Medical and Consumer Electricals.
Underlying operating margins year-to-date are around the top end of the 9-10% target range. That is being supported by pricing discipline, operational efficiencies and cost control. It is a healthy sign when revenue growth doesn’t come at the expense of profitability.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
31 viewsLikes
No ratings yet
On the balance sheet, net debt has reduced again through December. Covenant leverage is around 1.0x, helped by ongoing cash generation and tight working capital management. That gives Volex room to keep investing in capacity, automation and vertical integration, and to pursue disciplined M&A. In short, growth is not starving the business of cash.
Management now expects to beat full-year revenue consensus. For reference, as at 19 January 2026, the company-compiled average analyst forecast is $1,152.3 million (range: $1,145.1 million to $1,167.4 million). Underlying operating margins are projected to be sustained, and the Board has lifted its expectations for underlying operating profit from the prior view. The latest consensus average for underlying operating profit is $112.7 million (range: $111.7 million to $114.9 million).
Volex stops short of issuing new absolute numbers, but the direction of travel is clear: higher revenue than the market expected, with margins holding up, implies a positive bias to profit too.
This is another tidy print from Volex. The company is riding a powerful secular theme in Data Centres linked to AI, but doing so with pricing discipline and operational control that keep margins near the top of the target range. That combination tends to command investor respect.
The mixed read-through in Medical and Consumer Electricals is not surprising given the macro and customer-specific backdrop. Crucially, it is not derailing the story. With leverage around 1.0x and cash generation supporting investment, Volex has options to keep compounding.
Guidance ahead of consensus without stretching on margin is a high-quality upgrade. If they execute through Q4, the five-year plan targets referenced by management look increasingly credible. As ever, keep an eye on the demand cadence in EV and the timing of Medical destocking unwinds, but the runway from AI-driven infrastructure spending is the main event here.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.